Finance

Lists
NTLX:CVE
Neurothera Labs Inc
CAD 1,61
0,00%
(0,00) 1D
22 Okt., 09:30:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NTLX...
Mkt. cap
136,69 m
Avg. vol.
50,00
Volume
0,00
52-wk high
CAD 5,32
52-wk low
CAD 1,61
Beta
0,58
Shares outstanding
6,53 m
Mkt. cap
136,69 m
Avg. vol.
50,00
Volume
0,00
52-wk high
CAD 5,32
52-wk low
CAD 1,61
Beta
0,58
Shares outstanding
6,53 m
News stories
From web sources and news partners
About Neurothera Labs Inc
CEO-
Employees-
Founded2021
HeadquartersVancouver, Brits-Columbië, Kanada
SectorPharmaceutical industry
Websiteneurothera.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
236,00 k
159,00 k
142,50 k
142,50 k
Cost of goods sold
70,00 k
54,00 k
36,00 k
36,00 k
Cost of revenue
70,00 k
54,00 k
36,00 k
36,00 k
Research and development expenses
-
1,80 m
492,00 k
492,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
260,00 k
777,00 k
731,50 k
731,50 k
Operating expense
260,00 k
2,58 m
1,22 m
1,22 m
Total operating expenses
330,00 k
2,63 m
1,26 m
1,26 m
Operating income
-94,00 k
-2,47 m
-1,12 m
-1,12 m
Other non operating income
-
-1,41 m
-
-
EBT including unusual items
-94,00 k
-4,08 m
-1,10 m
-1,10 m
EBT excluding unusual items
-94,00 k
-3,96 m
-1,10 m
-1,10 m
Income tax expense
-
19,00 k
-
-
Effective tax rate
-
-0,47%
-
-
Other operating expenses
-
-
-
-
Net income
-94,00 k
-3,86 m
-1,06 m
-1,06 m
Net profit margin
-39,83%
-2 427,04%
-744,91%
-744,91%
Earnings per share
-
-
-
-
Interest and investment income
-
43,00 k
45,00 k
45,00 k
Interest expense
-
-125,00 k
-23,00 k
-23,00 k
Net interest expenses
-
-82,00 k
22,00 k
22,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,00 k
-2,42 m
-1,07 m
-1,07 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme